BMJ Best Practice

参考文献

关键文献

Drago F, Ciccarese G, Gasparini G, et al. Contemporary infectious exanthems: an update. Future Microbiol. 2017 Feb;12:171-93.

McFee RB. Tick borne illness - Rocky mountain spotted fever. Dis Mon. 2018 May;64(5):185-94.

Waldman R, Whitaker-Worth D, Grant-Kels JM. Cutaneous adverse drug reactions: kids are not just little people. Clin Dermatol. 2017 Nov - Dec;35(6):566-82.

National Institute for Health and Care Excellence. Fever in under 5s: assessment and initial management. August 2017 [internet publication].

参考文章

1.  van Lier A, Smits G, Mollema L, et al. Varicella zoster virus infection occurs at a relatively young age in The Netherlands. Vaccine. 2013 Oct 17;31(44):5127-33.

2.  Chovel-Sella A, Ben Tov A, Lahav E, at al. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics. 2013 May;131(5):e1424-7.

3.  Drago F, Ciccarese G, Gasparini G, et al. Contemporary infectious exanthems: an update. Future Microbiol. 2017 Feb;12:171-93.

4.  Treadwell PA. Papulosquamous disorders: atopic dermatitis, psoriasis, seborrheic dermatitis, and nickel contact dermatitis. Adolesc Med State Art Rev. 2011 Apr;22(1):157-68.

5.  Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015 Feb 1;91(3):185-90.

6.  Milingou M, Tagka A, Armenaka M, et al. Patch tests in children: a review of 13 years of experience in comparison with previous data. Pediatr Dermatol. 2010 May-Jun;27(3):255-9.

7.  Johnston GA, Exton LS, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of contact dermatitis 2017. Br J Dermatol. 2017 Feb;176(2):317-29.

8.  Marji JS, Marcus R, Moennich J, et al. Use of biologic agents in pediatric psoriasis. J Drugs Dermatol. 2010 Aug;9(8):975-86.

9.  Zawar V. Unilateral pityriasis rosea in a child. J Dermatol Case Rep. 2010 Dec 31;4(4):54-6.

10.  Hay RJ, Steer AC, Engelman D, et al. Scabies in the developing world - its prevalence, complications, and management. Clin Microbiol Infect. 2012 Apr;18(4):313-23.

11.  Usatine RP, Sandy N. Dermatologic emergencies. Am Fam Physician. 2010 Oct 1;82(7):773-80.

12.  McFee RB. Tick borne illness - Rocky mountain spotted fever. Dis Mon. 2018 May;64(5):185-94.

13.  National Institute for Health and Care Excellence. Lyme disease. October 2018 [internet publication].

14.  Heinzerling LM, Tomsitz D, Anliker MD. Is drug allergy less prevalent than previously assumed? A 5-year analysis. Br J Dermatol. 2012 Jan;166(1):107-14.

15.  Waldman R, Whitaker-Worth D, Grant-Kels JM. Cutaneous adverse drug reactions: kids are not just little people. Clin Dermatol. 2017 Nov - Dec;35(6):566-82.

16.  Belum VR, Benhuri B, Postow MA, et al. Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor. Eur J Cancer. 2016 Jun;60:12-25.

17.  Miliszewski MA, Kirchhof MG, Sikora S, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: an analysis of triggers and implications for improving prevention. Am J Med. 2016 Nov;129(11):1221-5.

18.  Bauer KA, Brimhall AK, Chang TT. Drug reaction with eosinophilia and systemic symptoms (DRESS) associated with azithromycin in acute Epstein-Barr virus infection. Pediatr Dermatol. 2011 Nov-Dec;28(6):741-3.

19.  Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part I. Clinical perspectives. J Am Acad Dermatol. 2013 May;68(5):693.e1-14; quiz 706-8.

20.  Baltimore RS, Gewitz M, Baddour LM, et al; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young and the Council on Cardiovascular and Stroke Nursing. Infective endocarditis in childhood: 2015 update: a scientific statement from the American Heart Association. Circulation. 2015 Oct 13;132(15):1487-515.

21.  Brewer JD, Hundley MD, Meves A, et al. Staphylococcal scalded skin syndrome and toxic shock syndrome after tooth extraction. J Am Acad Dermatol. 2008 Aug;59(2):342-6.

22.  Najib U, Sheikh J. An update on acute and chronic urticaria for the primary care provider. Postgrad Med. 2009 Jan;121(1):141-51.

23.  Chafen JJ, Newberry SJ, Riedl MA, et al. Diagnosing and managing common food allergies: a systematic review. JAMA. 2010 May 12;303(18):1848-56.

24.  Teachey DT, Lambert MP. Diagnosis and management of autoimmune cytopenias in childhood. Pediatr Clin North Am. 2013 Dec;60(6):1489-511.

25.  Rashtak S, Pittelkow MR. Skin involvement in systemic autoimmune diseases. Curr Dir Autoimmun. 2008;10:344-58.

26.  Hornor G. Medical evaluation for child physical abuse: what the PNP needs to know. J Pediatr Health Care. 2012 May-Jun;26(3):163-70; quiz 171-3.

27.  Dinakar C. Anaphylaxis in children: current understanding and key issues in diagnosis and treatment. Curr Allergy Asthma Rep. 2012 Dec;12(6):641-9.

28.  Sicherer SH, Simons FER. Epinephrine for first-aid management of anaphylaxis. Pediatrics. 2017 Mar;139(3).

29.  Wang J, Sicherer SH. Guidance on completing a written allergy and anaphylaxis emergency plan. Pediatrics. 2017 Mar;139(3).

30.  Meningitis Research Foundation. Meningococcal meningitis and sepsis: guidance notes. 2018 [internet publication].

31.  Heckenberg SG, Brouwer MC, van de Beek D, et al. Bacterial meningitis. Handb Clin Neurol. 2014;121:1361-75.

32.  National Institute for Health and Care Excellence. Meningitis (bacterial) and meningococcal septicaemia in under 16s: recognition, diagnosis and management. February 2015 [internet publication].

33.  Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013 Feb;41(2):580-637.

34.  Mirakian R, Ewan PW, Durham SR, et al. BSACI guidelines for the management of drug allergy. Clin Exp Allergy. 2009 Jan;39(1):43-61.

35.  Elzagallaai AA, Knowles SR, Rieder MJ, et al. Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Drug Saf. 2009;32(5):391-408.

36.  Shi YW, Min FL, Zhou D, et al. HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions. Neurology. 2017 Jun 6;88(23):2183-91.

37.  Saito M, Yagi M, Uno K, et al. Comparative study of the usefulness of the drug-induced lymphocyte stimulation test and the leukocyte migration test in drug allergies. Biol Pharm Bull. 2008 Feb;31(2):299-304.

38.  Webb R, Voss L, Roberts S, et al. Infective endocarditis in New Zealand children 1994-2012. Pediatr Infect Dis J. 2014 May;33(5):437-42.

39.  Webb RH, Grant C, Harnden A. Acute rheumatic fever. BMJ. 2015 Jul 14;351:h3443.

40.  Miyake CY, Gauvreau K, Tani LY, et al. Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. Pediatrics. 2007 Sep;120(3):503-8.

41.  Mathur AN, Mathes EF. Urticaria mimickers in children. Dermatol Ther. 2013 Nov-Dec;26(6):467-75.

42.  Tabel Y, Inanc FC, Dogan DG, et al. Clinical features of children with Henoch-Schonlein purpura: risk factors associated with renal involvement. Iran J Kidney Dis. 2012 Jul;6(4):269-74.

43.  Kellogg ND; American Academy of Pediatrics Committee on Child Abuse and Neglect. Evaluation of suspected child physical abuse. Pediatrics. 2007 Jun;119(6):1232-41.

44.  Jamieson N, Singh-Grewal D. Kawasaki disease: a clinician's update. Int J Pediatr. 2013;2013:645391.

45.  National Institute for Health and Care Excellence. Fever in under 5s: assessment and initial management. August 2017 [internet publication].

46.  American Academy of Pediatrics. Lyme disease. In Kimberlin DW, Brady MT, Jackson MA, et al, eds. Red book: 2015 report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015:516-525.

47.  Baker AL, Newburger JW. Cardiology patient page: Kawasaki disease. Circulation. 2008 Aug 12;118(7):e110-2.

48.  Van den Bruel A, Haj-Hassan T, Thompson M, et al. Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet. 2010 Mar 6;375(9717):834-45.

49.  Pite H, Wedi B, Borrego LM, et al. Management of childhood urticaria: current knowledge and practical recommendations. Acta Derm Venereol. 2013 Sep 4;93(5):500-8.

50.  Lipozencić J, Wolf R. The diagnostic value of atopy patch testing and prick testing in atopic dermatitis: facts and controversies. Clin Dermatol. 2010 Jan-Feb;28(1):38-44.

使用此内容应接受我们的免责声明